The forecast indicates an increasing trend in the number of multidrug-resistant tuberculosis (MDR-TB) cases started on treatment in Brazil from 2024 to 2028. The data shows a steady year-on-year increase, with the number of cases rising from 797 in 2024 to 852 in 2028. This trend suggests a nearly consistent annual growth rate of 1.3% when viewed as a compound annual growth rate (CAGR) over the five years. As of 2023, the actual number of MDR-TB cases began treatment was less than the projected figures in the subsequent years, reflecting a rising burden requiring attention.
Future trends to watch for include:
- The impact of healthcare policy changes on MDR-TB management and treatment accessibility.
- Potential advancements in medical technology and their effect on diagnosis and treatment efficacy.
- Changes in public health initiatives aimed at reducing MDR-TB transmission rates.
- The influence of international partnerships and funding on combating MDR-TB in Brazil.
